Publications by authors named "William C Cushman"

100Publications

Validation of a Health System Measure to Capture Intensive Medication Treatment of Hypertension in the Veterans Health Administration.

JAMA Netw Open 2020 Jul 1;3(7):e205417. Epub 2020 Jul 1.

VA Center for Clinical Management Research, Health Services Research and Development Center of Innovation, Ann Arbor, Michigan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamanetworkopen.2020.5417DOI Listing
July 2020

Outcomes in adults with systolic blood pressure between 130 and 139 mmHg in Action to Control Cardiovascular Risk in Diabetes Blood Pressure trial and Systolic Blood Pressure Intervention Trial.

J Hypertens 2020 Aug;38(8):1567-1577

aUniversity of Miami Miller School of Medicine, Miami, Florida bWake Forest School of Medicine, Winston-Salem, North Carolina cMiami Veterans Affairs Healthcare System, Miami, Florida dGeorgetown University, Washington, District of Columbia eRutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey fMedical University of South Carolina gRalph H. Johnson VA Medical Center, Charleston, South Carolina hUniversity of Kentucky, Lexington, Kentucky iEmory University School of Medicine, Atlanta, Georgia jUniversity of Utah School of Medicine, Salt Lake City, Utah kGeisinger Medical Center, Danville, Pennsylvania lMemphis Veterans Affairs Medical Center mUniversity of Tennessee Health Science Center, Memphis, Tennessee, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HJH.0000000000002437DOI Listing
August 2020

Influence of Prediabetes on the Effects of Intensive Systolic Blood Pressure Control on Kidney Events.

Am J Hypertens 2019 11;32(12):1170-1177

Division of Nephrology and Hypertension, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ajh/hpz105DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6856623PMC
November 2019

Blood pressure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Kidney Int 2019 05;95(5):1027-1036

KfH Kidney Center, Munich, Germany; Department of Nephrology and Hypertension, University Hospital, Friedrich-Alexander University, Erlangen-Nuremberg, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.kint.2018.12.025DOI Listing
May 2019

Lowering systolic blood pressure does not increase stroke risk: an analysis of the SPRINT and ACCORD trial data.

Ann Clin Transl Neurol 2019 01 28;6(1):144-153. Epub 2018 Nov 28.

Department of Neurology University of Tennessee Health Science Center Memphis Tennessee.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/acn3.693DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331200PMC
January 2019

Sprinting Toward the Optimal Blood Pressure Target for Hypertensive Patients.

Circ Res 2018 08;123(5):531-534

Division of Nephrology and Hypertension, Department of Medicine, Case Western Reserve University, Cleveland, OH (J.T.W.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCRESAHA.118.313057DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6922026PMC
August 2018

Comparison of Effectiveness of Azilsartan Medoxomil and Olmesartan in Blacks Versus Whites With Systemic Hypertension.

Am J Cardiol 2018 11 4;122(9):1496-1505. Epub 2018 Aug 4.

Calhoun Cardiology Center, University of Connecticut School of Medicine, Farmington, Connecticut.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00029149183149
Publisher Site
http://dx.doi.org/10.1016/j.amjcard.2018.07.022DOI Listing
November 2018

Rapid eGFR change as a determinant of cardiovascular and renal disease outcomes and of mortality in hypertensive adults with and without type 2 diabetes.

J Diabetes Complications 2018 Sep 11;32(9):830-832. Epub 2018 Jul 11.

Division of Nephrology and Hypertension, Case Western Reserve University, University Hospitals Case Medical Center, Louis Stokes Cleveland Veterans Affairs Medical Center, Cleveland, OH, United States of America.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jdiacomp.2018.07.003DOI Listing
September 2018

The 2017 U.S. Hypertension Guidelines: What Is Important for Older Adults?

J Am Geriatr Soc 2018 07 20;66(6):1062-1067. Epub 2018 May 20.

Department of Preventive Medicine, University of Tennessee Health Science Center, Memphis, Tennessee.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jgs.15395DOI Listing
July 2018

A new modeling and inference approach for the Systolic Blood Pressure Intervention Trial outcomes.

Clin Trials 2018 06 19;15(3):305-312. Epub 2018 Apr 19.

8 Division of Population Health and Computational Medicine, University of Miami and GRECC, Miami, FL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1740774518769865DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7288219PMC
June 2018

Blood Pressure Measurement in SPRINT (Systolic Blood Pressure Intervention Trial).

Hypertension 2018 05 12;71(5):848-857. Epub 2018 Mar 12.

From the Department of Preventive Medicine, University of Tennessee Health Science Center, Memphis (K.C.J., W.C.C.); Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA (P.K.W.); Preventive Medicine Section, Memphis Veterans Affairs Medical Center, TN (W.C.C.); Division of Cardiovascular Sciences (J.A.C., J.K.S.) and Clinical Applications and Prevention Branch (L.J.F.), National Heart, Lung, and Blood Institute; Division of Public Health Sciences, Department of Biostatistical Sciences (G.W.E., W.T.A., D.M.R.) and Section on Nephrology (M.V.R.), Wake Forest School of Medicine, Winston-Salem, NC; Division of Nephrology and Hypertension and Medical Service (S.B.) and Division of Nephrology and Hypertension (A.K.C.), Veterans Affairs Salt Lake City Healthcare System, University of Utah; Division of Preventive Medicine (C.E.L.) and Division of Cardiovascular Diseases (S.O.), University of Alabama at Birmingham; and Division of Nephrology and Hypertension, Louis Stokes Cleveland VA Medical Center (M.R.) and Division of Nephrology and Hypertension (J.T.W.), University Hospitals Cleveland Medical Center, Case Western Reserve University, OH.

View Article

Download full-text PDF

Source
https://www.ahajournals.org/doi/10.1161/HYPERTENSIONAHA.117.
Publisher Site
http://dx.doi.org/10.1161/HYPERTENSIONAHA.117.10479DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5967644PMC
May 2018

The Effects of eGFR Change on CVD, Renal, and Mortality Outcomes in a Hypertensive Cohort Treated With 3 Different Antihypertensive Medications.

Am J Hypertens 2018 04;31(5):609-614

Division of Nephrology and Hypertension, Case Western Reserve University, University Hospitals Case Medical Center, Louis Stokes Cleveland Veterans Affairs Medical Center, Cleveland, Ohio, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ajh/hpx223DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5905651PMC
April 2018

A Blood Pressure You Can Believe In.

Nephrol Nurs J 2017 Jan-Feb;44(1):57-71

Chief of the Preventive Medicine Section, the Veterans' Affairs Medical Center, Memphis, TN.

View Article

Download full-text PDF

Source
August 2018

Pharmacologic Treatment of Hypertension in Adults Aged 60 Years or Older.

Ann Intern Med 2017 08;167(4):290-291

From Memphis Veterans Affairs Medical Center and University of Tennessee Health Science Center, Memphis, Tennessee; Wake Forest University, Winston-Salem, North Carolina; and Consulting for Medical Research, Washington, DC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7326/L17-0284DOI Listing
August 2017

Visit-to-Visit Office Blood Pressure Variability and Cardiovascular Outcomes in SPRINT (Systolic Blood Pressure Intervention Trial).

Hypertension 2017 10 31;70(4):751-758. Epub 2017 Jul 31.

From the Division of Nephrology, Stanford University School of Medicine, CA (T.I.C., G.M.C.); Wake Forest School of Medicine, Winston-Salem, NC (D.M.R.); Division of Nephrology and Hypertension, University of Utah and Renal Section, Veterans Affairs Salt Lake City Health Care System (A.K.C.); Memphis Veterans Affairs Medical Center, TN (W.C.C.); Division of Cardiovascular Disease and Hypertension, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (W.J.K.); Department of Medicine and Surgery, University of Milano-Bicocca, Italy (G.P.); St. Luke Hospital, Italian Auxology Institute, Milan, Italy (G.P.); Division of Renal Diseases and Hypertension, George Washington University, Washington, DC (D.R.); Intermountain Medical Center, Murray, UT (E.R.); Department of Cardiovascular Diseases, Mayo Clinic, Jacksonville, FL (B.S.); School of Medicine, National and Kapodistrian University of Athens, Greece (G.S.S., K.T.); Perelman School of Medicine, University of Pennsylvania, Philadelphia (R.R.T.); Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA (P.K.W.); Primary Care Division, Clement J. Zablocki VA Medical Center, Milwaukee, WI (J.W.); Division of Nephrology and Hypertension, Case Western Reserve University, University Hospitals Cleveland Medical Center, OH (J.T.W.); and Department of Veterans Affairs and Georgetown University, Washington, DC (V.P.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/HYPERTENSIONAHA.117.09788DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6209591PMC
October 2017

Comparison of long-term safety of fixed-dose combinations azilsartan medoxomil/chlorthalidone vs olmesartan medoxomil/hydrochlorothiazide.

J Clin Hypertens (Greenwich) 2017 Sep 6;19(9):874-883. Epub 2017 Jul 6.

Takeda Pharmaceuticals International, Inc., Deerfield, IL, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/jch.13009
Publisher Site
http://dx.doi.org/10.1111/jch.13009DOI Listing
September 2017

Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial).

Circulation 2017 Aug 16;136(5):440-450. Epub 2017 May 16.

From Epidemiological Cardiology Research Center, Department of Epidemiology and Prevention, Division of Public Health Sciences (E.Z.S., Z.-M.Z.), Department of Medicine, Section on Cardiology (E.Z.S.), and Department of Biostatistical Sciences, Division of Public Health Sciences (W.T.A.), Wake Forest School of Medicine, Winston-Salem, NC; Preventive Medicine Section, Medical Service, Veterans Affairs Medical Center, Memphis, TN (W.C.C.); Michael E. DeBakey VAMC and Baylor College of Medicine, Houston, TX (J.T.B.); Division of Nephrology, Bone and Mineral Metabolism, Department of Internal Medicine, University of Kentucky, Lexington (J.A.N.); Charles and Jane Pak Center for Mineral Metabolism and Clinical Research and Division of Nephrology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas (J.A.N.); Department of Internal Medicine, Division of General Internal Medicine, Augusta University, GA (T.Y.C.); Division of Population Health and Computational Medicine, University of Miami, and Geriatric Research Education and Clinical Center, FL (L.T.); Department of Epidemiology, Division of Public Health, University of Minnesota, Minneapolis (L.G.); Division of Nephrology and Hypertension, University of Utah, Salt Lake City (M.E.C.); Department of Cardiovascular Diseases, Mayo Clinic, Jacksonville, FL (B.P.S.); Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA (J.H.); Clinical Applications and Prevention Branch, Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, Bethesda, MD (L.J.F.); and Division of Preventive Medicine, Department of Medicine, University of Alabama at Birmingham (C.E.L.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.117.028441DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5538944PMC
August 2017

Effect of Intensive Blood Pressure Treatment on Heart Failure Events in the Systolic Blood Pressure Reduction Intervention Trial.

Circ Heart Fail 2017 Apr;10(4)

From the Cardiovascular Medicine Section (B.U., C.J.R., D.W.K.), Nephrology Section, Department of Internal Medicine (M.R.), and Biostatistics (L.C.L.), Wake Forest School of Medicine, Winston-Salem, NC; Division of Preventive Medicine (C.E.L.) and Division of Cardiovascular Disease (S.O.), Department of Medicine, University of Alabama, Birmingham; Preventive Medicine Section, Veterans Affairs Medical Center, Memphis, TN (W.C.C.); Michael E. DeBakey Veterans Affairs Medical Center and Baylor College of Medicine, Houston, TX (J.T.B.); Cardiovascular Division, Department of Medicine, Columbia University Medical Center, New York, NY (N.A.B.); Department of Cardiology, University of Massachusetts Medical School, Worcester (G.A.); Clinical Applications and Prevention Branch, Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, Bethesda, MD (L.J.F.); Department of Preventive Medicine, University of Tennessee Health Science Center, Memphis (K.C.J.); Department of Medicine-Nephrology, George Washington University School of Medicine, DC (D.S.R.); Division of Nephrology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles (A.R.); University of Miami Miller School of Medicine, FL and Veterans Affairs Medical Center, Miami, FL (L.T.); and UH Harrington Heart and Vascular Institute, Cleveland Medical Center, OH (A.W.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCHEARTFAILURE.116.003613DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5384646PMC
April 2017

Serial Measurement of High-Sensitivity Troponin I and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus in the EXAMINE Trial (Examination of Cardiovascular Outcomes With Alogliptin Versus Standard of Care).

Circulation 2017 May 28;135(20):1911-1921. Epub 2017 Feb 28.

From University of North Carolina, Chapel Hill (M.A.C.); Calhoun Cardiology Center, University of Connecticut School of Medicine, Farmington (W.B.W.); Department of Pathology (P.J.) and TIMI Study Group (D.A.M.), Brigham and Women's Hospital and Harvard Medical School, Boston, MA; University of Chicago, IL (G.L.B.); Memphis Veterans Affairs Medical Center, University of Tennessee College of Medicine (W.C.C.); Takeda Development Center Americas, Inc., Deerfield, IL (S.K.); Baim Institute for Clinical Research, Boston, MA (Q.C., C.P.C.); Harvard School of Public Health, Boston, MA (C.R.M.); and Inserm 1143, Université de Lorraine, Nancy, France (F.Z.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.116.024632DOI Listing
May 2017

ACC/AHA Special Report: Clinical Practice Guideline Implementation Strategies: A Summary of Systematic Reviews by the NHLBI Implementation Science Work Group: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Circulation 2017 Feb 26;135(9):e122-e137. Epub 2017 Jan 26.

Implementation Science Work Group, National Heart, Lung, and Blood Institute. Center for Translation Research and Implementation Science; National Heart, Lung, and Blood Institute. Veterans Affairs Medical Center, Memphis, TN. Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute. American Institutes for Research conducted the systematic review under a contract with the National Heart, Lung, and Blood Institute.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIR.0000000000000481DOI Listing
February 2017

Blood-Pressure and Cholesterol Lowering in the HOPE-3 Trial.

N Engl J Med 2016 09;375(12):1194

Veterans Affairs Medical Center, Memphis, TN

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1608916DOI Listing
September 2016

Electrocardiographic measures of left ventricular hypertrophy in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.

J Am Soc Hypertens 2016 12 9;10(12):930-938.e9. Epub 2016 Nov 9.

Berman Center for Outcomes and Clinical Research, Minneapolis Medical Research Foundation, Minneapolis, MN, USA; Division of Clinical Epidemiology, Hennepin County Medical Center, Minneapolis, MN, USA; Department of Medicine, University of Minnesota Medical School, Minneapolis, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jash.2016.10.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5161112PMC
December 2016

Effect of Intensive Versus Standard Clinic-Based Hypertension Management on Ambulatory Blood Pressure: Results From the SPRINT (Systolic Blood Pressure Intervention Trial) Ambulatory Blood Pressure Study.

Hypertension 2017 01 14;69(1):42-50. Epub 2016 Nov 14.

From the Division of Renal Diseases and Hypertension, University of Minnesota, Minneapolis (P.E.D.); Department of Biostatistical Sciences, Division of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, NC (N.M.P.); Michael E. DeBakey Veterans Affairs Medical Center and Division of General Internal Medicine, Baylor College of Medicine, Houston, TX (J.T.B.); Division of Cardiology, Columbia University Medical Center, New York, NY (N.A.B.); Department of Medicine, Veterans Affairs Medical Center, Memphis, TN (W.C.C.); Division of Nephrology and Hypertension, Vanderbilt University Medical Center, Nashville, TN (J.P.D.); Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, Bethesda, MD (L.J.F.); Department of Epidemiology, Colorado School of Public Health, Aurora (D.C.G.); Nephrology and Hypertension Division, Mayo Clinic, Jacksonville, FL (W.E.H.); Departments of Medicine and Epidemiology, Ochsner Health System, Tulane University New Orleans, LA (M.K.-W.); Department of Family Medicine, Carolinas HealthCare System, Charlotte, NC (A.M.); Division of Nephrology, Veterans Affairs Health System and University of California, San Diego (D.E.R.); Division of Nephrology, Veterans Affairs Health System and University of Minnesota, Minneapolis (Y.S.); Michael E. DeBakey Veterans Affairs Medical Center and Division of Hypertension and Clinical Pharmacology, Baylor College of Medicine, Houston, TX (A.T.); Nephrology and Hypertension, University of Pennsylvania Medical Center, Philadelphia (R.T.); Veterans Affairs Medical Center and University of Tennessee Health Science Center, Memphis (B.W.); Division of Nephrology and Hypertension, University Hospitals Cleveland Medical Center, Case Western Reserve University, OH (J.T.W.); and Division of Nephrology and Hypertension, University Hospitals Cleveland Medical Center, Louis Stokes Cleveland VAMC, Case Western Reserve University, OH (M.R.).

View Article

Download full-text PDF

Source
http://hyper.ahajournals.org/content/early/2016/11/14/HYPERT
Web Search
http://dx.doi.org/10.1161/HYPERTENSIONAHA.116.08076DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5145774PMC
January 2017

Chlorthalidone Versus Hydrochlorothiazide: A New Kind of Veterans Affairs Cooperative Study.

Ann Intern Med 2016 11 16;165(9):663-664. Epub 2016 Sep 16.

From the Minneapolis Veterans Affairs Health Care System, Minneapolis, Minnesota; Veterans Affairs Medical Center, Memphis, Tennessee; and Veterans Affairs Boston Healthcare System, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7326/M16-1208DOI Listing
November 2016

Research Needs to Improve Hypertension Treatment and Control in African Americans.

Hypertension 2016 11 12;68(5):1066-1072. Epub 2016 Sep 12.

From the Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine (P.K.W., K.C.F.), and Department of Medicine, Tulane University School of Medicine (P.K.W., K.C.F.), New Orleans, LA; Division of Cardiovascular Sciences (P.T.E., P.D.-N., G.A.M., J.A.C.), and Center for Translation Research and Implementation Science (N.G., G.A.M.), National Heart, Lung, and Blood Institute, Bethesda, MD; Department of Epidemiology, School of Public Health, University of Alabama at Birmingham (P.M.); Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, Baltimore, MD (L.J.A., L.A.C., E.R.M.); Preventive Medicine Section, Veterans Affairs Medical Center, Memphis, TN (W.C.C.); Department of Epidemiology and Biostatistics, Dornsife School of Public Health, Drexel University, Philadelphia, PA (A.V.D.R.); Department of Medicine, Case Western Reserve University, University Hospitals Case Medical Center, Louis Stokes Cleveland VA Medical Center, OH (M.R., J.T.W.); Cardiovascular Research Institute, Morehouse School of Medicine, Atlanta, GA (H.A.T.); Department of Epidemiology and Prevention (J.A.) and Department of Medicine (B.I.F., J.A.), Wake Forest School of Medicine, Wake Forest University, Winston Salem, NC; Dean's Office, University of Kentucky College of Public Health, Lexington (D.K.A.); Department of Pharmacy Practice and Science, College of Pharmacy, University of Iowa, Iowa City (B.L.C.); Department of Biostatistics, University of Texas School of Public Health, Houston (B.R.D.); Department of Public Health Sciences, Stritch School of Medicine, Loyola University Chicago, Maywood, IL (R.C.); Division of Research, Kaiser Permanente Northern California, Oakland (A.S.G.); Department of Internal Medicine, Baylor College of Medicine, Houston, TX (D.J.H.); National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD (P.L.K.); HealthPartners Institute, Minneapolis, MN (K.L.M.); Duke Clinical Research Institute, Duke University Medical Center, Durham, NC (A.M.N.); Department of Population Health, NYU School of Medicine, New York (G.O.); American Medical Association, Chicago, IL (M.K.R.); Department of Nephrology and Hypertension, Cleveland Clinic, OH (G.T.); Clinical Directors Network (CND) and The Rockefeller University Center for Clinical and Translational Science, New York (J.N.T.); and National Center for Health Statistics, Centers for Disease Control and Prevention, Hyattsville, MD (S.S.(S.)Y.).

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063700PMC
http://dx.doi.org/10.1161/HYPERTENSIONAHA.116.07905DOI Listing
November 2016

Orthostatic Hypotension in the ACCORD (Action to Control Cardiovascular Risk in Diabetes) Blood Pressure Trial: Prevalence, Incidence, and Prognostic Significance.

Hypertension 2016 10 8;68(4):888-95. Epub 2016 Aug 8.

From the National Heart, Lung, and Blood Institute, Bethesda, MD (J.L.F., J.A.C.); Wake Forest University School of Medicine, Winston-Salem, NC (G.W.E., C.P.); Health Partners Institute for Education and Research, Minneapolis, MN (K.L.M., J.S.-H.); Kaiser Permanente of Georgia, Atlanta (J.B.); Medical University of South Carolina, Charleston (J.N.B.); Columbia University School of Medicine, New York, NY (J.T.B.); Berman Center for Outcomes and Clinical Research, Minneapolis, MN (R.G.); University of Minnesota School of Medicine, Minneapolis (K.P.); University of Michigan School of Medicine, Ann Arbor (R.P.-B.); and Veterans Affairs Medical Center, Memphis, TN (W.C.C.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/HYPERTENSIONAHA.116.07474DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5016241PMC
October 2016

Angiotensin-Converting Enzyme Inhibitor Use and Major Cardiovascular Outcomes in Type 2 Diabetes Mellitus Treated With the Dipeptidyl Peptidase 4 Inhibitor Alogliptin.

Hypertension 2016 09 1;68(3):606-13. Epub 2016 Aug 1.

From the Calhoun Cardiology Center, University of Connecticut School of Medicine, Farmington (W.B.W.); Takeda Development Center Americas, Inc, Deerfield, IL (C.A.W., S.K.); University of Chicago Medicine, IL (G.L.B.); International Diabetes Center, Park-Nicollet Clinic, Minneapolis, MN (R.M.B.); Brigham and Women's Hospital, Harvard Medical School, Boston, MA (C.P.C.); Memphis Veterans Affairs Medical Center, University of Tennessee College of Medicine (W.C.C.); University of Sheffield, United Kingdom (S.K.H.); Harvard School of Public Health, Boston, MA (C.R.M.); Cleveland Clinic Foundation, OH (S.E.N.); and Université de Lorraine, Nancy, France (F.Z.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/HYPERTENSIONAHA.116.07797DOI Listing
September 2016

The Association Between Antihypertensive Medication Nonadherence and Visit-to-Visit Variability of Blood Pressure: Findings From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.

Hypertension 2016 07 23;68(1):39-45. Epub 2016 May 23.

From the Center for Behavioral Cardiovascular Health, Columbia University Medical Center, New York, NY (I.M.K.); Department of Epidemiology (A.I.L., P.M.) and Division of Cardiology (S.O.), University of Alabama at Birmingham; Primary Care Division, Clement J. Zablocki VA Medical Center, Milwaukee, WI (J.W.); Coordinating Center for Clinical Trials, The University of Texas School of Public Health, Houston (B.R.D., L.M.S.); Department of Medicine, Tulane University School of Medicine, Department of Epidemiology, Tulane University School of Public Health, and Tropical Medicine, Research Division, Ochsner Health System (M.K.-W.); Preventive Medicine Section, Veterans Affairs Medical Center, Memphis, TN (W.C.C.); and Division of Nephrology, Department of Medicine, Stanford University School of Medicine, Palo Alto, CA (T.I.C.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/HYPERTENSIONAHA.115.06960DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4900942PMC
July 2016

Response to Budoff and Steigerwalt.

J Am Soc Hypertens 2016 05 23;10(5):470-1. Epub 2016 Mar 23.

University of Tennessee College of Medicine and Veterans Affairs Medical Center, Memphis, TN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jash.2016.03.181DOI Listing
May 2016

More HOPE for Prevention with Statins.

N Engl J Med 2016 May 2;374(21):2085-7. Epub 2016 Apr 2.

From the Preventive Medicine Section, Veterans Affairs Medical Center, Memphis, TN (W.C.C.); and the Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora (D.C.G.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMe1603504DOI Listing
May 2016

Patterns and Correlates of Baseline Thiazide-Type Diuretic Prescription in the Systolic Blood Pressure Intervention Trial.

Hypertension 2016 Mar 25;67(3):550-5. Epub 2016 Jan 25.

From the Division of Nephrology (T.I.C., R.S., G.M.C.) and Stanford Prevention Research Center (R.S.S.), Department of Medicine, Stanford University School of Medicine, Palo Alto, CA; Departments of Biostatistical Sciences (G.E.) and Internal Medicine (D.K.), Wake Forest School of Medicine, Winston-Salem, NC; Division of Nephrology and Hypertension, University of Utah, Salt Lake City (A.K.C.); Medical Service, Memphis Veterans Affairs Medical Center, TN (W.C.C.); Department of Medicine, The Medical College of Georgia, Georgia Regents University, Augusta (M.J.D.); Division of Nephrology and Hypertension, Department of Medicine (J.P.D.) and Department of General Internal Medicine and Public Health (C.L.R.), Vanderbilt University, Nashville, TN ; Renal, Electrolyte and Hypertension Division, Department of Medicine, University of Pennsylvania, Philadelphia (Y.H.); Departments of Medicine and Pharmacology, Robert Wood Johnson Medical School, New Brunswick, NJ (J.B.K.); Division of Cardiovascular Disease, Department of Medicine, University of Alabama at Birmingham (S.O.); Department of Medicine, University of California, Los Angeles (A.R.); VA Tennessee Valley Healthcare System Geriatrics Research and Education Clinical Center (GRECC), Nashville (C.L.R.); Medical Care Line, Michael E. DeBakey VA Medical Center, Baylor College of Medicine, Houston, TX (A.A.T.); and Department of Medicine, Case Western Reserve University, Cleveland, OH (J.T.W.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/HYPERTENSIONAHA.115.06851DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4755350PMC
March 2016

American Society of Hypertension position paper: central blood pressure waveforms in health and disease.

J Am Soc Hypertens 2016 Jan 5;10(1):22-33. Epub 2015 Nov 5.

Department of Medicine Service, Veterans Affairs Medical Center, University of Tennessee College of Medicine, Memphis, TN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jash.2015.10.012DOI Listing
January 2016

SPRINT Trial Results: Latest News in Hypertension Management.

Hypertension 2016 Feb 9;67(2):263-5. Epub 2015 Nov 9.

From Preventive Medicine Section, Veterans Affairs Medical Center, Memphis, TN (W.C.C.); Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA (P.K.W.); Clinical Applications and Prevention Branch, National Heart Lung and Blood Institute, Bethesda, MD (L.J.F.); Division of Nephrology and Hypertension, University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, OH (J.T.W.); Department of Biostatistical Sciences, Wake Forest School of Medicine, Winston-Salem, NC (D.M.R.); Department of Preventive Medicine, University of Tennessee Health Science Center, Memphis (K.C.J.); Division of Cardiovascular Disease, University of Alabama at Birmingham (S.O.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/HYPERTENSIONAHA.115.06722DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4768735PMC
February 2016

Impact of Non-Adherence on Renal and Cardiovascular Outcomes in US Veterans.

Am J Nephrol 2015 24;42(2):151-7. Epub 2015 Sep 24.

Division of Nephrology, University of California, Irvine, Calif., USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000440685DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4601642PMC
July 2016

Real-world evidence supports optimally dosed thiazide-type diuretics as preferred in treatment regimens of older adults with hypertension.

J Am Geriatr Soc 2015 May;63(5):1045-7

Division of Geriatrics and Clinical Gerontology, National Institute on Aging, National Institutes of Health, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jgs.13415DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4524522PMC
May 2015

Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Hypertension 2014 Nov 4;64(5):1012-21. Epub 2014 Aug 4.

From the Department of Epidemiology (P.M.) and Cardiovascular Disease (D.A.C.), University of Alabama at Birmingham; Coordinating Center for Clinical Trials, The University of Texas School of Public Health, Houston (B.R.D., S.L.P.); Preventive Medicine Section, Memphis Veterans Affairs Medical Center, TN (W.C.C.); Cardiovascular Outcomes Group, New York University School of Medicine (S.B.); New York University Langone Medical Center (H.R.B.); Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.B.K.); Clinical Trials Services Unit, University of Washington School of Medicine, Seattle (J.L.P.); Global Public Health, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA (P.K.W.); Division of Nephrology and Hypertension, Case Western Reserve University, University Hospitals Case Medical Center, Cleveland, OH (M.R.); and Louis Stokes Cleveland Veterans Administration Medical Center, Cleveland, OH (M.R.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/HYPERTENSIONAHA.114.03850DOI Listing
November 2014

Association of medical treatment nonadherence with all-cause mortality in newly treated hypertensive US veterans.

Hypertension 2014 Nov 4;64(5):951-7. Epub 2014 Aug 4.

From the Nephrology Division, Department of Medicine (E.O.G., J.L.L., C.P.K.) and Department of Preventive Medicine (W.C.C.), University of Tennessee Health Science Center, Memphis; Division of Nephrology, Department of Medicine, University of California, Irvine (E.S., K.K.-Z.); and Preventive Medicine Section (W.C.C.) and Nephrology Section (C.P.K.), Memphis Veterans Affairs Medical Center, TN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/HYPERTENSIONAHA.114.03805DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4192006PMC
November 2014

Chronic kidney disease and intensive glycemic control increase cardiovascular risk in patients with type 2 diabetes.

Kidney Int 2015 Mar 17;87(3):649-59. Epub 2014 Sep 17.

Veterans Affairs Medical Center, VA Clinical Center Network, Memphis, Tennessee, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ki.2014.296DOI Listing
March 2015

Proceedings from Duke resistant hypertension think tank.

Am Heart J 2014 Jun 28;167(6):775-88.e1. Epub 2014 Feb 28.

Division of Cardiology, Duke University Medical Center, Durham, NC; Duke Clinical Research Institute, Durham, NC. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ahj.2014.02.008DOI Listing
June 2014

Chlorthalidone versus hydrochlorothiazide in hypertension treatment: do we have the evidence to decide?

Am J Kidney Dis 2014 Mar 11;63(3):387-9. Epub 2013 Dec 11.

VA Medical Center, Minneapolis, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.ajkd.2013.11.009DOI Listing
March 2014